Tidewater Physicians Multispecialty Group has recently been awarded a new COVID-19 investigational treatment trial for patients with mild to moderate symptoms not requiring hospitalization.
The TPMG Clinical Research Division in Williamsburg is one of a handful of sites in the country that will be conducting the study.
TPMG board-certified pulmonologist Dr. Vijay Subramaniam will be the principal investigator on the therapeutic study and is looking for patients who have been recently diagnosed with the novel coronavirus.
In order to be considered for the study, participants must meet the following criteria: have been notified within 72 hours of a positive diagnosis for COVID-19, and present COVID-19 related symptoms (fever, cough, shortness of breath). All active participants will be compensated for their time.
“This is an incredible opportunity for the Williamsburg division, and we are proud to have been awarded this study,” said Subramaniam. “We hope the data we collect ...
To view the rest of this article, you must log in. If you do not have an account with us, please subscribe here.